跳至主要内容
临床试验/KCT0007245
KCT0007245招募中未知

Comparison of the incidence of delirium after transfemoral transcatheter aortic valve replacement under monitored anesthesia care with remimazolam versus dexmedetomidine

Asan Medical Center0 个研究点目标入组 186 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
186

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
65(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients 65 years of age or older who are scheduled to receive transfemoral TAVI under monitored anesthesia care

排除标准

  • ?. Patients scheduled for general anesthesia during TAVI
  • ?. Patients undergoing TAVI by a technique other than transfemoral TAVI (e.g., transapical TAVI, transcarotid TAVI, transaortic TAVI, etc.).
  • ?. Patients with preoperative delirium
  • ?. Patients receiving circulatory support before surgery, such as vasopressors, inotropes, and ECMO
  • ?. Patients who have a history of allergy to dexmedetomidine, opioids, or benzodiazepines
  • ?. Patients who are contraindicated to the use of dexmedetomidine, remimazolam, or remifentanil
  • ?. End-stage renal failure patients receiving dialysis
  • ?. Child-Pugh class C liver cirrhosis
  • ?. Patients deemed unsuitable for the study for other reasons by the researcher

研究者

相似试验